Skip to content
Clinical Trials – home

Stichting Meander Medisch Centrum

Verified siteinfo

The Netherlands Maatweg 3, 3813 TZ Amersfoort, The Netherlands

  • 4 trials recruiting
  • Chronic obstructive pulmonary disease · Acute coronary syndrome · Acute myeloid leukaemia
  • Adult patients

About Specializations

Stichting Meander Medisch Centrum in Amersfoort, The Netherlands specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Acute coronary syndrome, Acute myeloid leukaemia, Acute myocardial infarction, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The Cardiology department at Stichting Meander Medisch Centrum is advancing treatment options for patients with atrial fibrillation, focusing on safer anticoagulation to lower the risk of stroke and systemic embolism.

  • Comparative effectiveness of novel oral anticoagulants
  • Prevention of cardioembolic events
  • Safety and tolerability profiling in real‑world settings

These studies aim to refine therapeutic choices and improve long‑term outcomes for individuals at high cardiovascular risk.

Neoplasms

Research in the oncology sphere targets non–small cell lung cancer with a specific focus on tumors that are KRAS p.G12C positive and lack PD‑L1 expression, evaluating the benefit of targeted agents such as sotorasib alongside chemotherapy.

  • Targeted therapy for KRAS‑mutated lung cancer
  • Combination strategies with immunotherapy
  • Biomarker‑driven treatment selection

The goal is to enhance progression‑free survival and overall survival by personalizing treatment pathways for advanced disease patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Maatweg 33813 TZ AmersfoortThe Netherlands
Recruiting now
4 trials
Conditions studied
16
Partner status
Verified site

More sites in AmersfoortThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

15 clinical trials

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study of pirtobrutinib plus epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:Haemato Oncology Foundation For Adults Netherlands

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Radboud universitair medisch centrum Stichting

Hepatic cirrhosis

Not yet recruiting

Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Human Serum Albumin
  • Sponsor:Amsterdam UMC Stichting

Acute myeloid leukaemia

Not yet recruiting

Study on the Safety of Ivosidenib and Azacitidine for Adults with Newly Diagnosed IDH1m Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Servier Affaires Medicales

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Study on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Astegolimab
  • Sponsor:F. Hoffmann-La Roche AG

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.